Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Icos granted U.S. patent for rPAF-AH

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

APC-366 covered under U.S. patent

July 12, 1996

WAY-126120: Selective PDE IV inhibitor

July 12, 1996

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

Naphthoquinone derivative selected as potential antiallergic/antiinflammatory

July 5, 1996

Uriach research into PAF antagonists continues

July 5, 1996

New beclomethasone formulation cleared for marketing

July 5, 1996

Trials terminated for HyperGAM+ for Pseudomonas lung infections

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.